Study finds psoriatic arthritis burdens impact women more than men.

Over-the-counter products can help you effectively manage the symptoms of psoriasis and extremely dry skin.

When Michel Tarabocchia was in her darkest moments, she found NPF.

A highly detailed look at the presentations and discussions from Day 3 of 2022 Fall Clinical.

A highly detailed look at the presentations and discussions from Day 2 of 2022 Fall Clinical.

A highly detailed look at the presentations and discussions from Day 1 of 2022 Fall Clinical.

The health insurance market plan enrollment period has begun.

Too often people with darker skin tones struggle for an accurate diagnosis compared with those with fair skin.

Have you ever wondered about the role clinical trials might play in your treatment?

Inflammatory pathways, cytokine signaling, and inflammation-suppressive genes.

The next generation of community leaders is getting to work.

Did you know that PsA sits under the umbrella of diseases known as spondyloarthritis?

CEO Leah Howard, J.D., shares some thoughts and questions on why certain people develop disease or illness.

A new oral treatment option for adults with plaque psoriasis.

The first FDA approved treatment for generalized pustular psoriasis.

The NPF Medical Board addresses questions and considerations for those treating people with psoriatic disease.

NPF advocates continued momentum to ensure access to care for all.

The NPF Medical Board addresses key questions about monkeypox for people living with psoriatic disease.

Meet the woman selected to author the next pages in the epic tale of ending psoriatic disease.

Justin Elliott is getting ready to tackle 26.2 miles in honor of his late mom.

There is no easy fix, but better sleep is possible.

An expanded approval gives a new treatment option to children with psoriatic disease.

A new non-steroidal topical medication option for plaque and inverse psoriasis.